RxDoctor Payments Data

Agustin Vidal Rios, MD

Emergency Medicine · Manati, PRNPI 1093855017

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.0% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Johnson & Johnson at 48.2% of the total. Reporting peaked in 2019 at $864 and has fallen 80.2% since, to $171 in 2025. Among emergency medicine clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,406in general payments, 2019–2025

Across 44 payments — averaging $77.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • AstraZeneca$690
  • Abbott$260
  • Merck$200
  • Genentech USA, Inc.$175
  • E.r. Squibb & Sons, L.L.C.$125
  • plus $315 from 3 others

What the payments were for

  • Food & beverage$3,30497%
  • Education$1023%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson20$1,641
AstraZeneca12$690
Abbott2$260
Merck2$200
Genentech USA, Inc.2$175
E.r. Squibb & Sons, L.L.C.2$125
Bayer1$120
Chiesi USA, Inc.2$99
Pfizer Pharmaceuticals LLC1$97

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,406 in reported general payments places this provider in the 95th percentile of 214 emergency medicine providers in Puerto Rico.

See all emergency medicine providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$2,677
Medicare patients
28
Services billed
34

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Potassium43$1,052
CefuroximeCefuroxime Axetil21$567
Methylprednisolone27$267
Meclizine Hcl13$176
Famotidine27$137
Baclofen21$128
Ondansetron Hcl14$70

Paid to pharmacies, not to this prescriber.

Other emergency medicine in Manati

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →